BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31614716)

  • 1. DockNmine, a Web Portal to Assemble and Analyse Virtual and Experimental Interaction Data.
    Gheyouche E; Launay R; Lethiec J; Labeeuw A; Roze C; Amossé A; Téletchéa S
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides.
    Tanwar S; Auberger P; Gillet G; DiPaola M; Tsaioun K; Villoutreix BO
    Data Brief; 2022 Jun; 42():108159. PubMed ID: 35496477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FINDSITE
    Zhou H; Cao H; Skolnick J
    J Chem Inf Model; 2018 Nov; 58(11):2343-2354. PubMed ID: 30278128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping small molecule binding data to structural domains.
    Kruger FA; Rostom R; Overington JP
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S11. PubMed ID: 23282026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building a virtual ligand screening pipeline using free software: a survey.
    Glaab E
    Brief Bioinform; 2016 Mar; 17(2):352-66. PubMed ID: 26094053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain-based small molecule binding site annotation.
    Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
    BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTiOpenScreen: a web server for structure-based virtual screening.
    Labbé CM; Rey J; Lagorce D; Vavruša M; Becot J; Sperandio O; Villoutreix BO; Tufféry P; Miteva MA
    Nucleic Acids Res; 2015 Jul; 43(W1):W448-54. PubMed ID: 25855812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening.
    Nagamine N; Shirakawa T; Minato Y; Torii K; Kobayashi H; Imoto M; Sakakibara Y
    PLoS Comput Biol; 2009 Jun; 5(6):e1000397. PubMed ID: 19503826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDT - Drug Discovery Tool: a fast and intuitive graphics user interface for docking and molecular dynamics analysis.
    Aureli S; Di Marino D; Raniolo S; Limongelli V
    Bioinformatics; 2019 Dec; 35(24):5328-5330. PubMed ID: 31304963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. eModel-BDB: a database of comparative structure models of drug-target interactions from the Binding Database.
    Naderi M; Govindaraj RG; Brylinski M
    Gigascience; 2018 Aug; 7(8):. PubMed ID: 30052959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDTD: a web-accessible protein database for drug target identification.
    Gao Z; Li H; Zhang H; Liu X; Kang L; Luo X; Zhu W; Chen K; Wang X; Jiang H
    BMC Bioinformatics; 2008 Feb; 9():104. PubMed ID: 18282303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience.
    Bragina ME; Daina A; Perez MAS; Michielin O; Zoete V
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
    Mutowo P; Bento AP; Dedman N; Gaulton A; Hersey A; Lomax J; Overington JP
    J Biomed Semantics; 2016 Sep; 7(1):59. PubMed ID: 27678076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free resources to assist structure-based virtual ligand screening experiments.
    Villoutreix BO; Renault N; Lagorce D; Sperandio O; Montes M; Miteva MA
    Curr Protein Pept Sci; 2007 Aug; 8(4):381-411. PubMed ID: 17696871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of inhibitors targeting N-Terminal domain of human Replication Protein A.
    Çınaroğlu SS; Timuçin E
    J Mol Graph Model; 2019 Jan; 86():149-159. PubMed ID: 30366191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted Biological Activity of Purchasable Chemical Space.
    Irwin JJ; Gaskins G; Sterling T; Mysinger MM; Keiser MJ
    J Chem Inf Model; 2018 Jan; 58(1):148-164. PubMed ID: 29193970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
    Nowotka MM; Gaulton A; Mendez D; Bento AP; Hersey A; Leach A
    Expert Opin Drug Discov; 2017 Aug; 12(8):757-767. PubMed ID: 28602100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening.
    Zhou H; Cao H; Skolnick J
    J Chem Inf Model; 2021 Apr; 61(4):2074-2089. PubMed ID: 33724022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.